BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19690822)

  • 1. [Treatment of hypertension in patients older than 80 years].
    Rump LC; Nitschmann S
    Internist (Berl); 2009 Sep; 50(9):1169-70. PubMed ID: 19690822
    [No Abstract]   [Full Text] [Related]  

  • 2. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypertension in patients 80 years of age or older.
    Beckett NS; Peters R; Fletcher AE; Staessen JA; Liu L; Dumitrascu D; Stoyanovsky V; Antikainen RL; Nikitin Y; Anderson C; Belhani A; Forette F; Rajkumar C; Thijs L; Banya W; Bulpitt CJ;
    N Engl J Med; 2008 May; 358(18):1887-98. PubMed ID: 18378519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How controlling of hypertension might matter.
    Hara K; Kadowaki T
    Circ J; 2009 Dec; 73(12):2208-9. PubMed ID: 19940370
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
    Pella D
    High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON].
    Oganov RG; Nebieridze DV
    Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
    Huang SS; Wu TC; Lin SJ; Chen JW
    Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide.
    Myers MG; Asmar R; Leenen FH; Safar M
    J Hypertens; 2000 Mar; 18(3):317-25. PubMed ID: 10726719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
    Padma MV; Kaul S
    Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
    Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M;
    J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
    Davis SM; Donnan GA
    Stroke; 2003 May; 34(5):1335-6. PubMed ID: 12702835
    [No Abstract]   [Full Text] [Related]  

  • 17. The lowering of blood pressure after stroke.
    Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O
    Lancet; 2001 Dec; 358(9297):1995-6. PubMed ID: 11747948
    [No Abstract]   [Full Text] [Related]  

  • 18. The lowering of blood pressure after stroke.
    D'Ambrosio M
    Lancet; 2001 Dec; 358(9297):1993-4; author reply 1994-5. PubMed ID: 11747945
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
    Masson C
    Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
    [No Abstract]   [Full Text] [Related]  

  • 20. The lowering of blood pressure after stroke.
    Cates C
    Lancet; 2001 Dec; 358(9297):1993; author reply 1994-5. PubMed ID: 11747944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.